- Home
- BBWI vs VKTX Comparison
BBWI vs VKTX Comparison
Compare BBWI & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBWI | VKTX |
|---|---|---|
| Founded | 1963 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BBWI | VKTX |
|---|---|---|
| Price | $19.44 | $33.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | $24.88 | ★ $95.86 |
| AVG Volume (30 Days) | ★ 5.3M | 1.9M |
| Earning Date | 05-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $7,291,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.19 | N/A |
| P/E Ratio | $21.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.28 | $22.96 |
| 52 Week High | $32.32 | $43.15 |
Technical Indicators
Market Signals| Indicator | BBWI | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.15 | 47.04 |
| Support Level | $19.00 | $32.24 |
| Resistance Level | $19.88 | $35.24 |
| Average True Range (ATR) | 0.78 | 1.27 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 41.28 | 33.76 |
Price Performance
Historical ComparisonAbout BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.